|
| 摘要: |
|
| 关键词: 细胞周期 细胞周期蛋白依赖性激酶(CDK)抑制剂 肿瘤治疗olomoucine roscovitine flavopiridol butyrolactone |
| DOI： |
| 分类号: |
| 基金项目: |
|
| Cyclin-dependent kinase inhibitor: novel approaches for cancer therapy |
|
LUO Yun, HU Yong-zhou
|
| Abstract: |
| OBJECTIVE To systematically introduce the anticancer function of cyclin-dependent kinase inhibitor. METHOD Consulting the literature both in domestic and foreign, the development and action mechanism study of CDKs inhibitors were reviewed.RESULTS There |
| Key words: cell cycle cyclin dependent kinase(CDK) inhibitor cancer therapy olomoucine roscovitine flavopiridol butyrolactone |
